Failure of Viral-Specific T Cells Administered in Pre-transplant Settings in Children with Inborn Errors of Immunity.

Laura AlonsoAna Mendez-EchevarríaFrancesc RudillaYasmina MozoPere Soler-PalacinLuisa SisinniDavid BuenoJacques RiviereRaquel de PazElena Sánchez-ZapardielSergi QuerolRebeca Rodriguez-PenaEduardo López-GranadosRamón GimenoCristina Díaz de HerediaAntonio Pérez-Martínez

Published in: Journal of clinical immunology (2021)

In patients with inborn errors of immunity, the efficacy of VST for treating disseminated viral infections in pre-transplant settings seems to have a limited efficacy. However, this therapy could be used in a pre-emptive setting before severe viral disease occurs or closely to HSCT.

Keyphrases

sars cov
patient safety
young adults
adverse drug
early onset
bone marrow
electronic health record